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Introduction
Nodular regenerative hyperplasia (NRH) is a benign
proliferative lesion that has many synonyms, including
nodular transformation, partial nodular transforma-
tion and noncirrhotic nodulation.1,2 macroscopically,
NRH is characterized by multiple regenerative nodules
with varying sizes from 0.1 cm to 15 cm in groups.2–4
Microscopic features are very characteristic, revealing
diffuse micronodular transformation of the hepatic
parenchyma without fibrous septa between the regen-
erative nodules.3,5 The pathogenesis of NRH is not
well known. Based on large case series, the prevalence
of NRH ranges from 0.6% to 2.6%.6,7 NRH mostly
affects patients older than 60 years of age.6 The male-
to-female ratio is equal.6 NRH has been associated
with a variety of systemic diseases including collagen
vascular diseases, lymphoproliferative and myeloprolif-
erative disorders as well as some specific medications.6,7
Clinically, NRH usually does not cause symptoms and
is discovered incidentally unless it is complicated by
portal hypertension and its sequelae such as hepato-
megaly, splenomegaly, ascites, or esophageal varices.6,7
Imaging findings are nonspecific.7 In asymptomatic
patients, no treatment is recommended. In patients
with complications of portal hypertension, appropri-
ate treatments such as drug therapy and endoscopic
therapy are necessary.8–10
Case Report
A 39-year-old man visited our hospital due to inter-
mittent right upper abdominal dull pain for 1 week.
The dull pain was aggravated gradually but not asso-
ciated with meal and position. The patient denied any
nausea, vomiting, or changes in bowel or urinary
habits, and was without obvious body weight loss.
Thalassemia minor was first noted when he was a young
adult. He had no hepatitis or drug abuse history. Phys-
ical examination on admission showed mild pale con-
junctiva and a palpable mass with rubbery consistency
about 2 finger breadths below the right costal mar-
gin. The patient’s vital signs, including body tempera-
ture, pulse rate and respiratory rate, were all within
normal limits. Initial laboratory data were: aspartate
aminotransferase (AST) level of 21 IU/L (normal
range, 5–35 IU/L), alanine aminotransferase (ALT)
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level of 45 IU/L (normal, 0–40 IU/L), total biliru-
bin of 0.8 mg/dL (normal, 0.2–1.6 mg/dL), alkaline
phosphatase of 75 U/L (normal, 3.7–5.3 U/L), albu-
min of 4.9 g/dL (normal, 3.7–5.3 g/dL), normal pro-
thrombin time, white blood cell count of 12,990 cells/
mm3 (normal, 4,000–9,900 cells/mm3), hemoglobin
of 11.7 g/dL (normal, 13.5–17.8 g/dL), and platelet
count of 217,000 cells/mm3 (normal, 150,000–
450,000 cells/mm3). Viral serology was negative for
hepatitis B surface antigen and antibody to hepatitis
C virus. Serum α-fetoprotein level was normal. Fecal
occult blood test was negative. Renal function, elec-
trolytes and urine analysis were normal.
Abdominal ultrasonography revealed a large het-
erogeneous mass in liver segment 6 without halo 
sign, measuring about 5.6 × 4.7 cm. Liver parenchyma
appeared normal, and the spleen was not enlarged.
Hemangioma or hepatocellular adenoma was initially
diagnosed. Magnetic resonance (MR) of the liver,
using T1- and T2-weighted imaging, demonstrated a
nodular mass lesion, about 5.1 cm in size, with slight
hyperintensity on T2 and isointensity on T1 images,
in liver segment 6 (Figure 1). Focal nodular hyper-
plasia rather than hepatocellular adenoma was diag-
nosed by the radiologists. However, no characteristic
high T2 signal scar on the T2-weighted image was
disclosed.
Because of apparent right upper abdominal pain
related to the liver tumor, the patient requested surgi-
cal intervention. Thus, segmentectomy of S5 was per-
formed. The tumor was a solitary well-demarcated
nodule without fibrous capsular formation, measur-
ing about 6.3 × 6.1 × 3.5 cm (Figure 2). Neither hem-
orrhage nor necrosis was present. The hepatic surgical
margins were free of tumor grossly.
Microscopically, the liver tissue adjacent to the
large nodules was composed of vaguely multiple small
nodules with hepatocyte atrophy and bile ducts but
without fibrosis. In contrast, the hepatocytes were
arranged in 1 or 2 cell-thick plates in the large nodules.
Most hepatocytes had uniform regular nuclei, but a
focal area of moderately pleomorphic cells with dysplas-
tic nuclei (large-cell change) could be seen. Absence
of portal tracts and fibrosis was found. The large 
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Figure 1. Liver tumor appears as: (A) an isosignal on T1-weighted image; and (B) a slightly bright homogeneous signal on T2-weighted
imaging. Dynamic study shows: (C) early arterial enhancement of the tumor; and (D) iso-enhancement in the late phase.
nodules showed adenoma-like features. Furthermore,
staining for collagen with Masson trichrome showed
that fibrosis was absent. The overall findings were
considered to be NRH of the liver (Figure 3).
The patient was discharged after 13 days of hospi-
talization. During the 20-month follow-up period,
the patient became symptom-free and tumor-free
after liver resection.
Discussion
The etiology of NRH is not fully understood.10 At
present, the nodular transformation in NRH is con-
sidered to be a consequence of alterations in portal
blood flow.11 The “vascular hypothesis” presumes that
the basic pathologic injury leading to NRH is obliter-
ation and/or thrombus in the portal venous system.12
The central atrophy, produced by decreased blood
flow, is compensated for by proliferation of hepato-
cytes from the portal region that form regenerative
nodules. Most of the hepatocyte regeneration takes
place over the portal region.13 In addition, the portal
venous system shows abnormalities in NRH patients,
presenting with phlebosclerosis of the portal radicles
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Figure 2. Segmentectomy of S5 was performed. The tumor is a
solitary well-demarcated nodule without fibrous capsular formation,
measuring about 6.3 × 6.1 × 3.5 cm.
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Figure 3. (A) Gross photograph of nodularity shows biphasic pattern. The liver tissue adjacent to the large nodule shows vaguely multi-
ple small nodules (arrowheads) without fibrosis and preservation of hepatic architecture (hematoxylin & eosin, 40×). (B) More details of
typical nodularity in small nodules (hematoxylin & eosin, 100×). (C) In the large nodule, most hepatocytes are arranged in 2 cell-thick
plates, but a focal area of moderately pleomorphic cells with dysplastic nuclei (large cell change) can be seen (arrowheads) (hema-
toxylin & eosin, 400×). (D) Masson trichrome stain protocol for collagen fibers shows absence of fibrosis and presence of portal tracts
(arrowhead) and central veins (arrow) (100×).
and portal venule obliteration, the so-called “portal
obliterative venopathy”. Another theory is that NRH
is a primary generalized proliferative disorder of the
liver. Some investigators have advocated that NRH is
a premalignant lesion that may increase the incidence
of hepatocyte dysplasia and hepatocellular carcinoma.14
The pathogenesis of portal hypertension in this con-
dition may result from the compression of the intra-
hepatic portal radicles by the regenerating nodules or
due to the thrombosis of portal veins and venules.15
Clinical manifestations associated with NRH may
be nonspecific, including fatigue, general malaise or
abdominal pain. Long-term sequelae of NRH include
ascites, splenomegaly, hepatomegaly, portal hyperten-
sion, esophageal varices, cirrhosis, hepatic failure, and
hepatic rupture. The most common sequelae are cir-
rhosis and portal hypertension, with estimated fre-
quency of 30–50%. However, if the lesion is solitary,
as in this case, it may not induce any significant com-
plication. The clinical findings and laboratory tests are
variable and must be interpreted in view of the possi-
bility of primary systemic illness. Liver function tests
are usually normal or slightly elevated.15 There was
mild elevation of ALT in our patient. A number of sys-
temic diseases and drugs, such as myeloproliferative
syndromes, lymphoproliferative syndromes, rheuma-
toid arthritis, Felty’s syndrome, polyarteritis nodosa,
scleroderma, antiphospholipid syndrome, lupus erythe-
matosus, and the use of antineoplastic medication, have
been reported in association with NRH.16–21 However,
these conditions could not be traced in our patient.
NRH of the liver does not have characteristic radi-
ologic findings.7 At present, the best imaging tools are
non-contrast/contrast computed tomography (CT)
or MR. The important differential diagnoses of NRH
should include focal nodular hyperplasia and hepatic
adenoma (Table 1). Ultrasonography in most cases
shows normal hepatic parenchyma or well-delineated
hypoechoic or isoechoic nodules.3 Hyperechoic nod-
ules have been reported in very rare cases.2 Some-
times, a diffusely heterogeneous hepatic parenchyma
can be seen. Our case, manifesting as a solitary het-
erogeneous mass, is very different from the previous
reports. NRH, on enhanced CT, showed normal pa-
renchyma or hypoattenuating nodules. Hemorrhage
or arterioportal shunting are present in hyperattenu-
ating sections.7,22 MR examination may find hyperin-
tensity on T1-weighted images and iso- or hypointense
to normal liver on T2-weighted images.23,24 It is no
wonder that our case, slightly hyperintense on T2 and
isointense on T1 images, was misdiagnosed as focal
nodular hyperplasia rather than hepatocellular ade-
noma.25 Furthermore, most scintigraphic findings,
such as liver scan, demonstrated that the hyperplastic
nodules of NRH took up technetium sulfur colloid
but might not have a characteristic appearance.26,27
However, clinical and radiologic signs are not very
specific, and pathologic confirmation via needle biopsy
or operation is necessary to establish the diagnosis.
Many authors suggest open wedge biopsy because tis-
sue obtained by needle biopsy is seldom sufficient.2,3
Most hepatocytes are clustered into nodules that vary
in size from 0.1 cm to 1 cm, although a few nodules
measuring more than 10 cm have been reported.2–4,6
Histologically, the characteristics are pure liver cell
nodularity, abnormal hepatocyte plate arrangement
by 2 or more cells thick, and proliferating and distort-
ing acini and lobules. Vascular derangement of liver due
to portovenous or hepatovenous flow may also be pres-
ent.6,17 In the past, many cases of liver adenomatosis
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Table 1. Differential diagnosis of nodular regenerative hyperplasia of the liver—common radiologic features
NRH FNH HA
Ultrasound Rare detection Homogeneously isoechoic Complex heterogeneous
(iso- to hypoechoic) Central scar: hypoechoic
CT scan NECT: isodense NECT: iso- or hypodense NECT: iso- to hypodense
(NECT/CECT) CECT: iso- or hypodense CECT: arterial phase is hyperdense; CECT: arterial phase is 
in both phases venous phase is iso- or hypodense heterogeneous hyperdense; 
Central scar: hyperdense venous phase is variable
MR image T1: hyperintense T1: iso- to hypointense T1 & T2: heterogeneous signal
(T1/T2-weighted) T2: iso- or hypointense Scar: hypointense intensity (due to fat or hemorrhage)
T2: iso- to hyperintense
Scar: hyperintense
NRH = nodular regenerative hyperplasia; FNH = focal nodular hyperplasia; HA = hepatic adenoma; CT = computed tomography; MR = magnetic resonance;
NECT = non-contrast enhanced CT; CECT = contrast-enhanced CT.
were confused with NRH of the liver, and sometimes
the terms were used synonymously. Differentiating
NRH from liver adenomatosis is a very important rea-
son for sampling the tissue that surrounds the large
nodules. NRH can be easily distinguished from micro-
nodular cirrhosis, regenerative nodule and focal nodule
hyperplasia by the absence of fibrous septa between
the nodules. However, NRH is not clearly distin-
guishable from hepatic adenoma by only similarly
abnormal cell plates based on a single-needle biopsy.
Among benign lesions, NRH can mimic hepatocellu-
lar adenoma histologically, being composed of similar
liver cells arranged in sheets and cords without acinar
architecture, especially in small biopsies.
In conclusion, our case shows that NRH should be
included in the differential diagnosis of a benign liver
nodule. Clinical presentations and radiologic images are
not sufficiently specific to enable an accurate diagno-
sis in practice. Liver biopsy with a large tissue sample
is mandatory for diagnosis.
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